Citation Impact
Citing Papers
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
2007 Standout
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin
2004
Structure and Function of Leukocyte Integrins
1990
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding
1997
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Von Willebrand factor, platelets and endothelial cell interactions
2003
Uremic Bleeding: Pathogenesis and Therapy
1998
Relative contribution of the leukocyte molecules MO1, LFA‐1, and p150,95 (LeuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue‐ and stimulus‐specific
1988
Identification of Amino Acid Residues Essential for von Willebrand Factor Binding to Platelet Glycoprotein Ib.
1995
Solution Structure of Human von Willebrand Factor Studied Using Small Angle Neutron Scattering
2006
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
Photopolymerizable hydrogels for tissue engineering applications
2002 Standout
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex
1989
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
Platelet Activation and Atherothrombosis
2007 Standout
The coagulation cascade: initiation, maintenance, and regulation
1991 Standout
Identification of Three Tyrosine Residues of Glycoprotein Ibα with Distinct Roles in von Willebrand Factor and α-Thrombin Binding
1995
von Willebrand factor.
1997
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
2003 Standout
The Leukocyte Integrins
1989
Treatment of von Willebrand's Disease
2004
Identification of disulfide-bridged substructures within human von Willebrand factor
1987
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Hemodynamic Shear Stress and Its Role in Atherosclerosis
1999 Standout
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
2004 Standout
Adhesion receptors of the immune system
1990 StandoutNature
Resistance to Activated Protein C as a Basis for Venous Thrombosis
1994 Standout
Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins
1991 Standout
Sickle-cell disease
2010 Standout
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Endothelial Cell-Selective Materials for Tissue Engineering in the Vascular Graft Via a New Receptor
1991
von Willebrand's disease
1992
Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.
1989
150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen.
1991
The creation of an antithrombotic surface by apyrase immobilization
2010 StandoutNobel
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
A novel divalent cation-binding site in the a domain of the ?2 integrin CR3 (CD11b/CD18) is essential for ligand binding
1993
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
1994 Standout
A Pro51Ser mutation in the COCH gene is associated with late onset autosomal dominant progressive sensorineural hearing loss with vestibular defects
1999
BINDING OF THE VON WILLEBRAND FACTOR A1 DOMAIN TO HISTONE
1997
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin
1991
Slowed Release of Thrombin-cleaved Factor VIII from von Willebrand Factor by a Monoclonal and a Human Antibody Is a Novel Mechanism for Factor VIII Inhibition
1996
Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
1991
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site
1990 Standout
Extracellular DNA traps promote thrombosis
2010 Standout
Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures.
1992
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
1998 Standout
Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells.
1993
Effects of iodination of tyrosyl residues on the binding and action of glucagon at its receptor
1976 StandoutNobel
A3 Domain Is Essential for Interaction of von Willebrand Factor with Collagen Type III
1996
Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets
1993
Von Willebrand Disease: A Database of Point Mutations, Insertions, and Deletions
1993
Platelets and shear stress
1996
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
1996 Standout
Anionic Polysaccharides Inhibit Adhesion of Sickle Erythrocytes to the Vascular Endothelium and Result in Improved Hemodynamic Behavior
1999
Impact, Diagnosis and Treatment of von Willebrand Disease
2000
Iodoglucagon. Preparation and Characterization
1975
Effects of GTP on binding of (3H) glucagon to receptors in rat hepatic plasma membranes.
1977 StandoutNobel
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity
2000
A Revised Classification of von Willebrand Disease
1994
Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.
1989
Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains.
1986
The Platelet Glycoprotein Ib-IX-V Complex
2017
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Domains involved in multimer assembly of von willebrand factor (vWF): multimerization is independent of dimerization.
1990
Improvement of von Willebrand Factor Proteolysis After Prostacyclin Infusion in Severe Pulmonary Arterial Hypertension
2000
Developing relationships: arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoproteins
1991
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
1993 Standout
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
1991 Standout
Platelet phosphatidylserine exposure and procoagulant activity in clotting whole blood – different effects of collagen, TRAP and calcium ionophore A23187
2003 StandoutNobel
Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene
1990
Endothelial Leukocyte Adhesion Molecule 1: an Inducible Receptor for Neutrophils Related to Complement Regulatory Proteins and Lectins
1989 StandoutScience
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Analysis of the Structure and Function of the von Willebrand Factor A1 Domain Using Targeted Deletions and Alanine-Scanning Mutagenesis
1996
von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene
1995
Sulfation of von Willebrand factor
1990
Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed.
1994 StandoutNobel
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
1990 StandoutScience
The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor
1995
Disulfide bonds required to assemble functional von Willebrand factor multimers.
1994
Mechanisms Initiating Platelet Thrombus Formation
1997
Low-Molecular-Weight Heparins
1997 Standout
Third-Generation Biomedical Materials
2002 StandoutScience
Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network
2007
Results of a Screening for von Willebrand Disease Type 2N in Patients with Suspected Haemophilia A or von Willebrand Disease Type 1
1996
Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib
1991
Kinetics of factor VIII-von Willebrand factor association
1996
Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
1997
Localization of binding sites within human von Willebrand factor for monomeric type III collagen
1986
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Type 2M von Willebrand Disease: F606I and I662F Mutations in the Glycoprotein Ib Binding Domain Selectively Impair Ristocetin- but not Botrocetin-Mediated Binding of von Willebrand Factor to Platelets
1998
A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor.
1987
Analysis of structure-function relationships in the platelet membrane glycoprotein Ib-binding domain of von Willebrand's factor by expression of deletion mutants
1993
Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III.
1987
Primary structure of the leukocyte function-associated molecule-1 alpha subunit: an integrin with an embedded domain defining a protein superfamily.
1989
Bacterial synthesized cellulose — artificial blood vessels for microsurgery
2001 Standout
Adhesion Mechanisms in Platelet Function
2007
Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation.
1988
Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations.
1992
A sensitive ELISA for von Willebrand factor (vWf:Ag)
1987
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction
1999 Standout
A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction
1990
Works of JP Girma being referenced
The von Willebrand factor self-association is modulated by a multiple domain interaction
2005
Role of von Willebrand Factor in Platelet Vessel‐Wall Interactions
1987
Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods
2003
Structure-function relationship of human von Willebrand factor
1987
Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies
1986
New variant of von Willebrand disease with defective binding to factor VIII
1989
Mediation of platelet adhesion to fibrillar collagen in flowing blood by a proteolytic fragment of human von Willebrand factor
1986
Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor
1987
Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease.
1982
SYNTHETIC RGD-CONTAINING PEPTIDES OF VON WILLEBRAND FACTOR INHIBIT PLATELET ADHESION TO COLLAGEN
1987
Structure-function relationship of human von Willebrand factor
1987
Ristocetin and Botrocetin Involve Two Distinct Domains of von Willebrand Factor for Binding to Platelet Membrane Glycoprotein lb
1990
“Variants” of von Willebrand's disease. Demonstration of a decreased antigenic reactivity by immunoradiometric assay
1978
Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease
1994
Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factor
1994
Impaired Prothrombin Consumption in Bernard-Soulier Syndrome Is Corrected In Vitro by Human Factor VIII
1997
Aurin Tricarboxylic Acid Inhibits Platelet Adhesion to Collagen by Binding to the 509-695 Disulphide Loop of von Willebrand Factor and Competing with Glycoprotein Ib
1992
Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1,365
1987
The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673
1991
Functional Analysis of the Arg91GIn Substitution in the Factor VIII Binding Domain of von Willebrand Factor Demonstrates Variable Phenotypic Expression
1993
Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies
1986
Estimation of the von Willebrand Factor-cleaving Protease in Plasma Using Monoclonal Antibodies to vWF
1999
Preparation of iodo derivatives and high specific activity 3H synthetic human gastrin I
1974
von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein Ib.
1988
Mediation of platelet adhesion to fibrillar collagen in flowing blood by a proteolytic fragment of human von Willebrand factor
1986
Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely
1992
Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
1983
Ser968Thr Mutation within the A3 Domain of Von Willebrand Factor (VWF) in Two Related Patients Leads to a Defective Binding of VWF to Collagen
2001
Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1,365
1987
Processing and Characterization of Recombinant von Willebrand Factor Expressed in Different Cell Types Using a Vaccinia Virus Vector
1992
The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673
1991
Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
1990